ALOX15 and asthma: Given the central role of pro-ferroptotic lipid metabolism in this asthma subtype, targeting arachidonate 15-lipoxygenase (ALOX15)—which is highly expressed in neutrophilic infiltrates—has emerged as a rational therapeutic strategy.